FDA defends Aduhelm's accelerated approval, while others call for reform

Regulatory NewsRegulatory NewsAdvertising, Promotion and LabelingBiologicsClinical TrialsEthicsFDA meeting and communication strategyNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy